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1. Introduction 
For screening and detailed studying of antidiabetic medications, various genetic and non-
genetic experimental models of diabetes mellitus were used (Islam S., Loots D.T. 2009). And 
though they are not absolutely equivalent to etiopathogenetic mechanisms of human 
pathological conditions, each of them represents itself as an integral tool for research into 
genetic, endocrine, metabolic, morphological changes of this disease (Sarvilina I.V., 
Maclakov Y.S. 2008). 
The most commonly used diabetic experimental models are non-genetic models that use 
hydrophilic β-cell glucose analogues, such as alloxan, streptozotocin, chlorozotocin, 
cyproheptadine, etc. The common mechanism of action of these substance includes 
degradation of pancreatic islet β-cells by means of: 1) generation of oxygen free radicals that 
destroy the integrity of a cell, 2) alkylation of DNA and subsequent activation of poly-ADP-
ribose-synthetase - reduction of NAD to β-cell, and 3) inhibition of active transport of 
calcium and calmodulin-activated protein kinase (Rees D.A., Alcolado J.C. 2005). In this type 
of experimental models of diabetes mellitus streptozotocin (an N-nitrosourea derivative of 
glucosamine) is most commonly used (McNeill J.H. 1999). Depending on cytotoxin dosage 
used in the experiment (45-70 mg/kg) and route of administration (i.p., i.v.), it is possible to 
model and simulate different states of carbohydrate metabolism based on a specific clinical 
type of diabetes mellitus (DM mixed (type 1-2) latent or «hidden» diabetes) (Srinivasan K. et 
al. 2007). Although diabetes mellitus usually has obvious clinical symptoms such as 
hyperglycemia, glucosuria, polyuria, polydipsia, severe weight loss, it is difficult to measure 
the contribution of each of the links to the pathogenesis of diabetes and to assess the extent 
of pancreatic islet β-cell damage and death. The toxic effect of alloxan and streptozotocin on 
cells in pancreatic islets manifests itself not only by necrosis but also by apoptosis of 
pancreatic islet β-cells (Daisy Mythili M., et al. 2004). The study of apoptotic mechanisms 
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will enable us to identify specific targets for purposeful creation and development of anti-
diabetic medications. 
2. Materials and methods 
The experiments were performed on 180 adult male Wistar rats weighing from 280.0 to 300.0 
g (Table 1). The animals were kept under standard vivarium conditions at pharmacology 
department of Volgograd Medical University, and were provided with a nutritionally 
balanced diet that the laboratory animals consume consistently. A pilot study was approved 
by the Central Regional Independent Ethics Committee (protocol № 1-06; № 43-2006; № 70-
2008; № 89-2009), and was performed in accordance with GLP when conducting preclinical 
studies in Russia. All animal experimentation was carried out in compliance with the 
International Guidelines of the European Convention for the Protection of Vertebrate 
Animals used in experimental studies (1997). 
 
Group Day of experiment 
Amount of 
animals 
Intact control 3, 7, 14, 28 40 
Alloxan-induced diabetes 3, 7, 14, 28 40 
Streptozotocin-induced diabetes 7, 28 20 
Immune-dependent diabetes 3, 7, 14, 28 40 
Streptozotocin-nicotinamide-induced diabetes 3, 7, 14, 28 40 
Table 1. Group distribution of experimental animals  
Plasma glucose, insulin and C-peptide concentrations were measured in experimental 
laboratory animals. The blood glucose was determined in samples obtained from the tail 
vein of rats by enzymatic method, using "Glucose FKD" assay kits (Russia) on SF-46 
spectrophotometer at λ=450 nm in 10 mm cuvettes. Animals with blood glucose levels >15 
mmol/L were enrolled in the experiment (Akbarzadeh A. et al. 2007). Plasma insulin and C-
peptide concentrations were determined on an automated enzyme immunoassay 
«SUNRISE» analyzer (TECAN, Austria), using DRG Insulin ElisaKit and DRG C-peptide 
ElisaKit. 
Alloxan-induced diabetes simulation model was developed by means of intraperitoneal 
administration of alloxan at a dose of 120 mg/kg. Tissue samples of animals were collected 
and submitted for routine histopathological investigation at 3, 7, 14 and 28 days of the 
experiment. 
Experimental streptozotocin-induced diabetes simulation model was developed using 
streptozotocin (Sigma) (45 mg/kg, intravenously once a day) (Baranov V.G. 1983). Tissue 
samples were collected and submitted for routine histopathological investigation at 7 and 28 
days of the experiment. 
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Experimental immune-dependent diabetes simulation model was developed by giving a 
subcutaneous injection of 0.2 ml of complete Freund's adjuvant (CFA) (Grand Island Biological 
Company, USA). Subsequently, daily intravenous injections of streptozotocin (Sigma, USA) 
(20 mg/kg) were given to the animals for 5 days, resulting in the development of insulin-
dependent diabetes (Ziegler B. 1990). Tissue samples were collected and submitted for routine 
histopathological investigation at 3, 7, 14 and 28 days of the experiment. 
Streptozotocin-nicotinamide-induced diabetes model was developed by giving an injection 
of streptozotocin (Sigma, USA) (intraperitoneally - 65 mg/kg citrate buffer, pH = 4.5) with a 
preliminary (15 minutes prior to the procedure) administration of nicotinamide 
(intraperitoneally - 230 mg/kg prepared in 0.9 % solution of sodium chloride) (Islam S., et al. 
2009). Tissue samples were collected and submitted for routine histopathological 
investigation at 3, 7, 14 and 28 days of the experiment. 
Pancreatic tissue was divided into three segments including intestinal, gastric and splenic 
parts, and then they were fixed in 10% solution of neutral buffered formalin (pH 7.4) for 24 
hours. 5-6-mm thick slices were obtained on rotary microtomes and were mounted on 
slides. Tissue sections were stained with hematoxylin and eosin using standard histological 
stain techniques (Korzhevsky D.E. 2005). 
For detection of α-and β- endocrine cells in the islets of Langerhans the primary antibodies 
against insulin and glucagon were used (Table 2). To study apoptosis, the primary 
antibodies to proteins, such as caspase 3, TRAIL (TNF-related apoptosis-inducing ligand), 
MDM2, Bcl 2, p53, Bax, NF-kB, as well as eNOS were used. 
 
№ Antibody Clone Manufacturer
1 Insulin Polyclonal DakoCytomation, Denmark 
Ab-6 (INS04 + INS05) LabVision, UK 
2D11-H5 Novocastra, UK 
2 Glucagon Polyclonal Novocastra, UK 
3 Caspase 3 JHM62 Novocastra, UK 
Rb-1197-P0 NeoMarkers, USA 
4 TRAIL 27B12 Novocastra, UK 
5 MDM2 1B10 Novocastra, UK 
6 Bcl 2 sc-7382 Santa Cruz Biotechnology, USA 
124 Dako Cytomation, Denmark 
7 p53 Polyclonal Dako Cytomation, Denmark 
Ab-1 (Pab 240) MS-104-
P0 
NeoMarkers, USA 
8 Bax Polyclonal BD Biosciences Pharmingen, USA 
9 NOS-3 RN5 Novocastra, UK 
10 NF-kB Polyclonal Diagnostic BioSystems, USA 
Table 2. IHC Primary Antibodies  
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Immunohistochemistry was performed according to manufacturers' protocols using ABC 
(Novocastra, UK), «UltraVision» (Lab Vision, UK) and «EnVision» (Dako Cytomation, 
Denmark) antibody detection systems and a chromogen, diaminobenzidine under the 
protocol on high temperature antigen unmasking technique using «Pascal» mini autoclave 
(Dako Cytomation, Denmark) (Kumar G.L. et al. 2009). The reliability of the obtained results 
was defined using both positive and negative control antigens, as well as negative control 
antibodies. 
Immunohistochemical reaction was based on visual evaluation, taking into account the 
intensity of color, or on determination of the specific amount of positively stained cells 
(Allred DC, et al. 1998). 
Photo images were captured with an «AxioScope» microscope (Carl Zeiss, Germany) and a 
«PowerShot» digital camera (Canon, Japan). Morphometric analysis was performed using 
"VideoTestMorfo-4" software (Russia). In the course of the study we determined the 
relationship between the total α-and β- endocrine cell area and the total area of the islet 
(S,%), between the volume fraction (ML, %) of islets and exocrine glands, as well as the area 
of β-cell nuclei (S, µm2). We also measured apoptotic index (AI), i.e. the relative amount of 
β-endocrine cells with apoptotic structural and immunohistochemical changes. 
The research results were processed using basic statistical analysis techniques as well as 
"Video TestMorfo-4», Excel Microsoft Office (Microsoft, USA) and STATISTICA 6.0 software 
(StatSoft Inc., USA). The analysis of the parameters for normally-distributed values was 
performed using Student's t test. Nonparametric statistics was calculated using Mann-
Whitney test. To compare qualitative variables, the chi-square test and the Fisher exact test 
were used. Differences were considered significant if error probability was p <0.05. 
3. Results 
All animals in the intact control group showed stable plasma biochemical parameters which 
did not exceed the physiological norms during an observation period (glucose - 4,02 ± 0,1 
mmol/L (Fig. 1), insulin - 1,65 ± 0,04 mU/ml., C-peptide - 4,65 ± 0,16 ng/ml. 
Morphological study of the intact control group showed that the exocrine part of the pancreas 
has an alveolar-tubular structure which exhibited a division into lobules separated by 
interlobular connective tissue. Exocrinotcytes tended to be highly differentiated and they 
formed acini. Pancreatic islets in all parts of the pancreas were round or slightly oval in shape. 
They were single or were arranged in clusters around the intralobular excretory ducts. The 
total volume fraction of islet tissue in the gastric and splenic segments was almost twice as 
much as the volume fraction of islets of the intestinal segment (Table 3). The total area of 
nuclear β-endocrine cells in all segments of the pancreas had no statistically significant 
differences during all periods of observation. Insulin-positive cells were predominantly found 
in the central part of the pancreatic islets; however, glucagon-positive cells were more 
frequently encountered at the periphery. In this case there was a statistically significant 
increase (p <0.05) in β-cell area of the splenic segment compared with the intestinal and gastric 
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segments of the pancreas (Fig. 2A). The maximum α-endocrine cell area was determined in the 
intestinal and gastric segments of the pancreas; however, this area was statistically significant 
lower (p <0.05) in the splenic segment (Table 3). There was a statistically significant (p ≤ 0.05) 
direct relationship between the total volume fraction of pancreatic islets and the area of β- 
endocrine cells depending on their location. The amount of islets and β-endocrine cells tended 
to increase in the following segments of the pancreas: intestinal →gastric → splenic. 
 
Figure 1. Blood glucose dynamics (mmol/L) in rats with different models of experimental diabetes. * - 
Significant changes compared with the intact control group. 
 
Indicator Day of experiment 
Segment of the pancreas 
Intestinal Gastric Splenic 
Volume fraction 
of islets,% 
3 6,8±2,5 12,6±6,0 13,8±7,3 
7 6,7±2,2 12,0±4,5 12,9±2,1 
14 6,9±3,1 12,1±5,2 14,0±2,9 
28 6,6±4,2 12,8±4,5 14,3±5,2 
Total area of β-
cells,% 
3 51,3±9,2 64,6±9,1 78,2±6,1** 
7 53,8±7,6 63,4±7,0 75,4±8,7** 
14 52,1±5,5 64,5±8,7 79,4±4,6** 
28 54,3±5,4 66,2±3,6 77,3±4,3** 
Total area of α-
cells,% 
3 37,4±5,2 31,2±3,5 22,2±3,4** 
7 39,3±4,3 30,4±4,0 21,3±3,0** 
14 38,5±3,5 32,4±3,2 19,7±2,3** 
28 37,1±1,0 30,2±1,2 17,9±1,3** 
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Indicator Day of experiment 
Segment of the pancreas 
Intestinal Gastric Splenic 
Total area of β-
cell nuclei, µm2 
3 24,2±1,2 24,4±1,0 23,9±0,2 
7 24,3±1,3 23,8±1,2 24,7±1,0 
14 24,3±1,2 24,8±1,3 24,6±1,3 
28 24,4±1,0 24,3±1,2 24,7±2,0 
* - Significant difference in the intestinal segment of the pancreas (p <0.05), 
** - Significant difference in the gastric segment of the pancreas (p <0.05). 
Table 3. Morphometric indicators of pancreatic islets in the intact control group (M ± m). 
Bax protein expression was negative in all islet cells. A weak positive cytoplasmic staining 
of islet cells in the central part of the islet for Bcl-2 protein was reported. In the nuclei of 
individual β-endocrine cells ambiguous or weak expression of p53 protein was determined. 
Most of β-islet cells had a positive nuclear staining for MDM2 protein. In some β-endocrine 
cells cytoplasmic expression of caspase 3 and TRAIL was poorly defined or ambiguous 
(Table 4) (Fig.3A, 4A). Apoptotic index was low (Table 5). 
 
Group 
Day of 
experiment 
Primary antibodies   
p53 Caspase-
3 
TRAIL Bax Bcl-
2 
MDM2 NOS-
3 
NF-
kB 
Intensity of expression
Intact 
control 
3 - + + - + ++ - ++ 
7 - + + - + ++ - ++ 
14 - + + - + ++ - ++ 
28 - + + - + ++ - ++ 
Amount of cells
Intact 
control 
3 - + + - + +++ - ++ 
7 - + + - + +++ - ++ 
14 - + + - + +++ - ++ 
28 - + + - + +++ - ++ 
Table 4. Immunohistochemical characteristics of β-cells 
Alloxan-induced diabetes  
In alloxan-induced diabetes simulation model a significant increase in blood glucose of rats 
compared with the intact control was reported (Fig. 1). 
At day 3 of the experiment a well pronounced interstitial edema associated with hyperemia 
of blood vessels and capillaries in the acinar tissue of pancreatic islets was determined 
histologically. Compared with the intact control group, the total volume fraction of the 
pancreatic islets was not significantly reduced. However, there was a slight decrease in the 
area of β-cells in all segments of the pancreas (Table 5). The cells with moderate dystrophic 
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and destructive changes were revealed in the central part of the islets of Langerhans. 
Immunohistochemical reaction in the central part of the pancreatic islets revealed insulin-
positive cells with marked expression of insulin. A slight increase in the size of β-cell nuclei 
was reported. Compared with the intact control group, the total area of islet cells in all 
segments of the pancreas was slightly reduced. The total glucagon-positive cell area did not 
change as compared with the control group (Table 5). 
At day 7 the islets were swollen, hyperemic and collapsed. There was no statistically 
significant reduction in the total volume fraction of islets in all segments of the pancreas. In the 
central part of the islets we observed moderate necrobiotic changes associated with a 
significant decrease (p <0.05) in the total β-cell area predominantly in the gastric and splenic 
segments when compared with the intact control group (Table 5). There was a statistically 
significant increase (p <0.05) in the area of α-endocrine cells in the gastric and splenic segments 
of the pancreas. β-cell necrosis was accompanied by moderate leukocyte infiltration of the 
stroma and acinar cells with only few leukocytes in the islets. The area of nuclear β-islet cells in 
all segments of the pancreas increased by 4.5 µm2; however, no statistically significant changes 
were identified when compared with the intact control group. 
Edema significantly reduced by day 14; however, blood vessels of the acinar tissue and 
capillaries of the islets of Langerhans were still slightly hyperemic. There were focal sclerotic 
changes in some islets. Compared with the control group, there were not any statistically 
significant changes in the islet volume fraction in all segments of the pancreas. Insulin-
positive cells tended to be located in a random pattern; however, glucagon-positive cells 
were predominantly found at the periphery. The total β-endocrine cell area in the gastric 
and splenic segments, as compared with the intact control group, was significantly 
decreased (p <0.05), while the total α-cell area was increased (p <0.05) (Table 5) (Fig.2B). 
There was moderate hypertrophy of β-cell nuclei in all segments of the pancreas. 
At 28 day edema, hyperemia of blood vessels and inflammatory infiltration were replaced 
by focal sclerotic changes of the acinar tissue and pancreatic islets. As before, a slight 
decrease in the islet volume fraction in all segments of the pancreas was reported. Also, in 
all segments of the pancreas the total area of β-cells was slightly increased, compared with 
day 14 of the experiment, but was significantly lower (p <0.05) as compared with the 
animals in the intact control group. The volume fraction of α-endocrine cells slightly 
decreased but was statistically greater (p <0.05) than in the intact control group (Table 5). 
The average area of nuclei was slightly decreased as compared with the intact control group 
and with day 14 of the experiment. 
 
Indicator Day of experiment
Segment of the pancreas
Intestinal Gastric Splenic 
Volume 
fraction of 
islets,% 
3 intact 6,8±2,5 12,6±6,0 13,8±7,3 
diabetes 6,7±2,1 11,8±5,4 13,9±10,2 
7 intact 6,7±2,2 12,0±4,5 12,9±2,1 
diabetes 4,5±3,1 11,2±3,2 11,1±5,2 
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Indicator Day of experiment
Segment of the pancreas
Intestinal Gastric Splenic 
14 intact 6,9±3,1 12,1±5,2 14,0±2,9 
diabetes 4,2±1,4 8,4±1,6 9,3±2,1 
28 intact 6,8±2,1 11,9±3,7 13,7±3,2 
diabetes 3,1±1,1 7,6±2,3 9,5±2,4 
Total area 
of β-cells, % 
3 intact 51,3±9,2 64,6±9,1 78,2±6,1 
diabetes 50,4±8,5 65,9±8,2 69,8±4,9 
7 intact 53,8±7,6 63,4±7,0 75,4±7,7 
diabetes 42,2±2,1 45,5±1,4* 58,1±1,4* 
14 intact 52,1±5,5 64,5±8,7 79,4±4,6 
diabetes 40,4±2,4 39,7±2,2* 57,4±2,0* 
28 intact 51,1±7,5 65,2±6,0 77,4±4,4 
diabetes 32,3±1,3* 40,2±1,4* 49,7±2,1* 
Total area 
fraction of 
α-cells,% 
3 intact 37,4±5,2 31,2±3,5 22,2±3,4 
diabetes 36,5±4,8 30,8±2,5 25,7±2,4 
7 intact 39,3±4,3 30,4±4,0 21,3±3,0 
diabetes 41,1±4,1 49,3±2,1* 35,4±2,2* 
14 intact 38,5±3,5 32,4±3,2 19,7±2,3 
diabetes 32,2±1,5 47,4±2,0* 32,2±2,1* 
28 intact 30,0±4,4 31,4±3,9 18,9±3,2 
diabetes 30,1±2,1* 42,3±3,1* 30,1±4,1* 
Total area 
of β-cell 
nuclei, µm2 
3 intact 24,2±1,2 24,4±1,0 23,9±0,2 
diabetes 27,8±5,9 27,5±5,5 26,6±4,6 
7 intact 24,3±1,3 23,8±1,2 24,7±1,0 
diabetes 29,5±4,3 28,4±3,2 29,6±4,3 
14 intact 24,3±1,2 24,8±1,3 24,6±1,3 
diabetes 30,3±3,2 29,6±2,3 30,4±3,4 
28 intact 23,9±1,2 24,2±1,2 24,6±1,2 
diabetes 28,5±5,1 27,4±3,4 28,5±4,0 
* - Significant difference compared with the intact control group (p <0.05). 
Table 5. Morphometric indicators of pancreatic islets in rats with alloxan-induced diabetes (M ± m) 
Immunohistochemical study which, was performed at day 3 and day 28, showed negative 
staining of β-endocrine cells for p53, TRAIL, endothelial NO-synthase and Bcl-2 proteins 
(Fig. 3B) in all segments of the pancreas. At day 3 we observed mild cytoplasmic staining for 
anti-caspase-3 and anti-Bax-antibody in some endocrine cells. Compared with the intact 
control group, apoptotic index was significantly increased (p <0.05) during all observation 
periods. The expression of NF-kB and MDM2 proteins tended to decrease. At 7-14 day 
moderate cytoplasmic staining for caspase-3 and Bax proteins accompanied by decreased 
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amount of cells with NF-kB-and MDM2-positive stained nuclei was reported. At day 7 there 
was a significant (p <0.05) increase in the amount of apoptotic β-cells, compared with day 3 
of the experiment, which was followed by a significant (p <0.05) decrease by day 14 (Table 
12). At day 28 the amount of cells and the intensity of expression of apoptotic markers 
significantly decreased and anti-apoptotic proteins were expressed in large quantities in the 
endocrine cells of pancreatic islets. Apoptotic index was significantly decreased as 
compared with day 7; however, it was still statistically more significant than in the intact 
control group (Table 6). 
 
Group 
Day of 
experiment 
Primary antibodies   
p53 
Caspase-
3 
TRAIL Bax
Bcl-
2 
MDM2
NOS-
3 
NF-
kB 
Intensity of expression
Intact 
control 
3 - + + - + ++ - ++ 
7 - + + - + ++ - ++ 
14 - + + - + ++ - ++ 
28 - + + - + ++ - ++ 
Diabetes 3 - + - + - ++ - ++ 
7 - ++ - ++ - + - + 
14 - ++ - ++ - + - + 
28 - + - + - ++ - ++ 
Amount of cells
Intact 
control 
3 - + + - + +++ - ++ 
7 - + + - + +++ - ++ 
14 - + + - + +++ - ++ 
28 - + + - + +++ - ++ 
Diabetes 3 - + - + - + - + 
7 - ++ - ++ - ++ - + 
14 - ++ - ++ - ++ - + 
28 - + - + - ++ - + 
Table 6. Immunohistochemical characteristics of β-endocrine cells in alloxan-induced diabetes 
Within the period from day 7 to day 14 we observed cytoplasmic staining for caspase-3 and 
Bax proteins accompanied by decreased amount of cells with NF-kB-and MDM2-positive 
stained nuclei (Fig. 4B). At day 7 there was a significant (p <0.05) increase in the amount of 
apoptotic β-cells compared with day 3 of the experiment, which was followed by a 
significant (p <0.05) decrease by day 14 (Table 12). 
Thus, in alloxan-induced diabetes we observe a decrease in the total β-cell area from day 7 
to day 28 of observation which is accompanied by a simultaneous increase in the total α-cell 
area. These changes occur in all segments of the pancreas; however, they are predominantly 
obvious and are statistically significant in the gastric and splenic segments. Along with 
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pronounced necrotic changes in the cells of the insular apparatus of the pancreas, there is 
also an increase in apoptogenic activity of β-endocrine cells due to the damage to 
mitochondrial membranes (increased expression of Bax and inhibition of Bcl-2 proteins), 
which might be caused by impaired intracellular calcium homeostasis and activation of the 
mitochondrial apoptotic pathway with subsequent activation of caspase cascade without the 
involvement of p53 protein (Table 12). 
Streptozotocin-induced diabetes 
In streptozotocin-induced diabetes a statistically significant elevation of plasma glucose 
levels, as compared with those in the intact control animals, was reported (Fig. 1). 
Histological investigation which was performed at day 7 showed pronounced hyperemia of 
blood vessels associated with lymphocytic infiltration and marked edema of the interlobular 
connective tissue. There were not any statistically significant differences in the total volume 
fraction of islets either with regard to the intact control group, or to different segments of the 
pancreas. We revealed marked necrotic changes in endocrine cells both in the central part 
and at the periphery of the islets (Fig. 2C). We also stated a statistically significant decrease 
(p <0.05) in the area of β-cells in all segments of the pancreas. However, a significant 
increase (p <0.05) in the volume fraction of α-cells exclusively in the gastric and splenic 
segments of the pancreas was reported. There was marked hypertrophy of β-islet cell nuclei 
(p <0.05) predominantly in the splenic segment of the pancreas (Table 7). 
By day 28 moderate hyperemia of blood capillaries of pancreatic islets and accumulation of 
lymphocytes at some sites were observed. Focal necrotic changes were reported in some islets, 
whereas other islets underwent sclerotic changes. No significant changes in the islet volume 
fraction were observed. The total β-islet cell area was still significantly lower (p <0.05) 
compared with the intact control group during the same period of observation. The total 
volume fraction of α-endocrine cells was significantly increased (p <0.05) exclusively in the 
splenic segment of the pancreas. The nuclei of β-cells were hypertrophic and hypertrophy was 
statistically significant (p <0.05) in the cells of the splenic segment of the pancreas (Table 7). 
 
Indicator 
Day of 
experiment 
Segment of the pancreas
Intestinal Gastric Splenic 
Volume 
fraction of 
islets,% 
7 intact 6,7±2,2 12,0±4,5 12,9±2,1 
diabetes 4,7±3,1 10,2±6,7 11,8±1,5 
28 intact 6,8±2,1 11,9±3,7 13,7±3,2 
diabetes 3,2±2,1 8,2±3,1 9,7±2,3 
Total area of 
β-cells,% 
7 intact 53,8±7,6 63,4±7,0 75,4±8,7 
diabetes 24,3±2,1* 39,2±3,2* 40,1±2,0* 
28 intact 51,1±7,5 65,2±6,0 77,4±4,4 
diabetes 29,8±5,5* 43,2±5,4* 47,7±8,2* 
Total area of 
α-cells,% 
7 intact 39,3±4,3 30,4±4,0 21,3±3,0 
diabetes 44,2±4,5 42,3±2,2* 29,8±2,1* 
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Indicator 
Day of 
experiment 
Segment of the pancreas
Intestinal Gastric Splenic 
28 intact 40,0±4,4 31,4±3,9 18,9±3,2 
diabetes 40,9±4,8 42,7±4,8 30,3±4,7* 
Total area of 
β-cell nuclei, 
µm2 
7 intact 24,3±1,3 23,8±1,2 24,7±1,0 
diabetes 23,8±3,1 25,7±2,5 29,5±1,8* 
28 intact 23,9±1,2 24,2±1,2 24,6±1,2 
diabetes 25,3±1,2 25,9±1,0 29,3±1,1* 
* - Significant difference compared with the intact control group (p <0.05). 
Table 7. Morphometric indicators of pancreatic islets in rats with streptozotocin-induced diabetes (M ± m) 
Immunohistochemical reaction, which was performed at day 7, revealed that most 
endocrine cells exhibited marked expression of proapoptotic proteins, such as caspase-3, 
TRAIL and Bax (Fig. 3C, 4C). Activation of apoptosis was accompanied by inhibited 
expression of anti-apoptotic Bcl-2, MDM2, nuclear factor NF-kB proteins (Table 8). There 
was a statistically significant increase in the amount of cells with morphological features of 
apoptosis when compared with the intact control group (Table 8). 
By day 28 there was a decrease in the amount of β-cells as well as in the intensity of 
expression of caspase 3 in the surviving cells (Table 12). We did not observe any significant 
changes in expression of either mitochondrial proapoptotic Bax protein or membrane TRAIL 
(Table 8). Compared with the intact control group, there was a statistically significant 
increase in apoptotic index. With regard to day 7 of observation, a statistically significant 
decrease in apoptotic index was stated (Table 8). Moderate expression of endothelial NO-
synthase in the capillaries of pancreatic islets was found during all observation periods 
(Table 8). 
 
Characteristic 
Day of 
experiment 
Primary antibodies   
p53 
Каспаза-
3 
TRAIL Bax
Bcl-
2 
MDM2
NOS-
3 
NF-
kB 
Intensity of expression
Intact control 7 - + + - + ++ - ++ 
28 - + + - + ++ - ++ 
Diabetes 7 - +++ + ++ - + + + 
28 - ++ + ++ - + + + 
Amount of cells
Intact control 7 - + + - + +++ - ++ 
28 - + + - + +++ - ++ 
Diabetes 7 - ++ + + - + + + 
28 - + + + - ++ + ++ 
Table 8. Immunohistochemical characteristics of β-endocrine cells in streptozotocin-induced diabetes 
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Thus, the development of streptozotocin-induced diabetes is associated not only with 
hyperglycemia, but also with marked necrotic changes in endocrine cells of pancreatic islets, 
decreased β-islet cell area accompanied by hyperplasia of their nuclei, increased α-
endocrine cell area, as well as increased apoptotic index (Table 12). High expression levels of 
endothelial NO-synthase in the capillaries of pancreatic islets are indicative of endothelial 
dysfunction. 
Immune-dependent diabetes 
Persistent hyperglycemia and a reduction in plasma insulin by 67.8% were reported in 
immune-dependent diabetes (Fig. 1), as compared with the intact control group. 
Microscopic examination, which was performed at day 7, found that the total volume 
fraction of the islets decreased when compared with the intact control group. The islets had 
an irregular shape due to marked necrotic changes in the endocrine cells, hyperemia of the 
capillaries, as well as mild lymphocytic infiltration. There were single insulin-positive cells 
or they were arranged in small clusters in the central part of the islets around the capillaries. 
We observed a significant decrease (p <0.05) in the total β-cell area in all segments of the 
pancreas as compared with the intact controls (Table 9). The total α-endocrine cell area was 
significantly increased exclusively in the splenic segment of the pancreas. 
At day 14 some symptoms of insulitis, i.e. inflammation of insular cells, persisted. 
Compared with the intact control group, the area covered by β-endocrine cells in all 
segments of the pancreas tended to become smaller (p <0.05) due to marked necrotic 
changes in β-endocrine cells (Fig. 2D). However, we observed moderate hypertrophy of the 
nuclei of β-islet cells as well as an increase in the area covered by α-endocrine cells in the 
splenic segment of the pancreas (Table 9). Some pancreatic islets were reported to undergo 
sclerotic changes. 
By day 28, as before, a statistically significant reduction (p <0.05) in the area covered by β-
islet cells in all segments of the pancreas, as compared with the intact control group, was 
observed. Inflammatory infiltration, swelling and hyperemia of blood vessels tended to 
reduce, too. However, the amount of islets which developed sclerotic changes increased and 
β-endocrine cells had moderately hypertrophic nuclei. There was an increase in the area 
covered by α-endocrine cells in the gastric and splenic segments of the pancreas (Table 9). 
 
Indicator 
Day of 
experiment 
Section of the pancreas
Intestinal Gastric Splenic 
Volume 
fraction of 
islets,% 
7 intact 6,7±2,2 12,0±4,5 12,9±2,1 
diabetes 4,7±3,1 10,2±6,7 11,8±1,5 
14 intact 6,9±3,1 12,1±5,2 14,0±2,9 
diabetes 4,2±1,2 8,9±2,0 9,2±2,2 
28 intact 6,8±2,1 11,9±3,7 13,7±3,2 
diabetes 4,4±1,0 7,4±1,3 8,7±3,4 
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Indicator 
Day of 
experiment 
Section of the pancreas
Intestinal Gastric Splenic 
Total area of 
β-cells,% 
7 intact 53,8±7,6 63,4±7,0 75,4±8,7 
diabetes 29,8±5,5* 43,2±5,4* 47,7±8,2* 
14 intact 52,1±5,5 64,5±8,7 79,4±4,6 
diabetes 25,4±3,2* 40,1±3,2* 42,3±1,2* 
28 intact 51,1±7,5 65,2±6,0 77,4±4,4 
diabetes 30,2±4,5* 44,3±2,3* 40,1±3,2* 
Total area of 
α-cells,% 
7 intact 39,3±4,3 30,4±4,0 21,3±3,0 
diabetes 45,2±1,2 40,4±5,1 56,7±4,6* 
14 intact 38,5±3,5 32,4±3,2 19,7±2,3 
diabetes 44,1±2,1 42,3±4,2 56,4±3,4* 
28 intact 40,0±4,4 31,4±3,9 18,9±3,2 
diabetes 33,9±3,2 49,5±4,4* 50,9±3,2* 
Total area of 
β-cell nuclei, 
µm2 
7 intact 24,3±1,3 23,8±1,2 24,7±1,0 
diabetes 25,8±1,1 25,2±2,3 27,5±2,2 
14 intact 24,3±1,2 24,8±1,3 24,6±1,3 
diabetes 25,6±2,3 24,6±2,3 26,4±2,1 
28 intact 23,9±1,2 24,2±1,2 24,6±1,2 
diabetes 24,9±2,0 25,1±1,2 25,8±2,2 
* - Significant difference compared with the intact control group (p <0.05). 
Table 9. Morphometric indicators of pancreatic islets in rats with insulin-dependent diabetes (M ± m) 
Immunohistochemical study during all observation periods showed absence or doubtful 
expression of p53, Bax, MDM2 as well as Bcl-2 proteins in certain β-islet cells. Within the 
period from day 7 to day 14 we observed increased expression of TRAIL proapoptotic 
protein and caspase 3 protein (compared with the intact control group and at day 14 
compared with day 7 of the experiment) (Table 10, 12, Fig. 3D, 4D) in most β-cells 
accompanied by a slight reduction by day 28. Simultaneously, apoptotic index during all 
observation periods was significantly increased compared with the intact control group 
(Table 5). The expression of NO-synthase in the endothelium of the pancreatic islet 
capillaries during all observation periods enhanced. 
 
Group 
Day of 
experiment, 
days 
Primary antibodies   
p53 Caspase-3 TRAIL Bax Bcl-2 MDM2 NOS-3 
NF-
kB 
Intensity of expression
Intact 
control 
7 - + + - + ++ - ++ 
14 - + + - + ++ - ++ 
28 - + + - + ++ - ++ 
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Group 
Day of 
experiment, 
days 
Primary antibodies   
p53 Caspase-3 TRAIL Bax Bcl-2 MDM2 NOS-3 
NF-
kB 
Diabetes 7 - +++ +++ ++ - + ++ + 
14 - +++ ++ ++ - + ++ + 
28 - ++ + + - ++ ++ + 
Amount of cells 
Intact 
control 
7 - + + - + +++ - ++ 
14 - + + - + +++ - ++ 
28 - + + - + +++ - ++ 
Diabetes 7 - ++ + ++ - ++ + + 
14 - ++ + ++ - ++ + + 
28 - ++ + + - ++ + + 
Table 10. Expression of pro-and β-anti-apoptotic proteins in endocrine cells of insulin-dependent 
diabetic rats 
Thus, it was found that immuno-dependent diabetes is characterized by the following 
changes: hyperglycemia, reduced area of β-islet cells, inflammatory infiltration of islets, 
marked β-necrotic changes in endocrine cells, focal sclerosis of the islets of Langerhans. 
Streptozotocin-nicotinamide-induced diabetes 
The results of the 28-day streptozotocin-nicotinamide-induced diabetes study indicated that 
plasma C-peptide concentration in the control animals with diabetes increased by 36.8% 
(p<0,05), as compared with intact rats. Blood glucose levels in rats with strep-tozototsin-
nicotinamide-induced diabetes during the entire experiment was significantly superior to 
glycemia in intact animals (Fig. 1). 
Histologically, the maximum reduction in the volume fraction of islets was found at day 3 
with a tendency to increase by day 28 in all segments of the pancreas. 
At day 3 the pancreatic tissue appeared unevenly swollen and hyperemic. There were minor 
destructive changes of endocrine cells in pancreatic islets. The proportion of β-islet cells in 
all segments of the pancreas markedly decreased. At the same time no significant changes in 
the area of β-cells in islets were observed. The islets showed uneven accumulation of 
insulin-positive cells. Along with the cells which exhibited a marked accumulation of 
insulin, endocrine cells showing uneven distribution of immunopositive material in the 
cytoplasm with moderate or weak staining were singled out. Endocrine cells in the splenic 
segment of the pancreas were characterized by moderate hypertrophy of the nuclei and it 
was statistically significant, as compared to the intact control (Table 11). 
By day 7 swelling hyperemia decreased and a microscopic mosaic image was observed. Both 
histologically intact and impaired islets of Langerhans were found. In a number of islets we 
could observe focal necrotic changes of endocrine cells, while others exhibited focal 
proliferation of connective tissue, and sometimes poorly defined intralobular and periductal 
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sclerotic changes. Compared with the intact control group, there was a statistically 
significant reduction in the area of β-cells in the splenic segment. Immunopositive material 
was unevenly distributed both in the insular cells and within the cytoplasm of an insular 
cell. Hypertrophy of the nuclei of islet cells was reported in all segments of the pancreas. 
At day 14 a mosaic pattern of cell damage was still noted. Both histologically intact islets 
and islets revealing sclerotic changes were defined. Their amount tended to decrease in all 
segments of the pancreas. Simultaneously, the total β-cell area decreased in the gastric and 
splenic segments of the pancreas. Hypertrophy of the nuclei of β-cells persisted in all 
segments of the pancreas (Fig. 2E). 
By day 28 a statistically significant reduction in β-cell area in the gastric segment of the 
pancreas was reported, as compared with the control group. Hypertrophy of the nuclei of β-
cells persisted (Table 11). 
 
Indicator Day of experiment 
Segment of the pancreas
Intestinal Gastric Splenic 
Total volume 
fraction of 
islets,% 
3 intact 6,8±2,5 12,6±6,0 13,8±7,3 
diabetes 3,8±1,0 8,3±1,0 5,4±3,2 
7 intact 6,7±2,2 12,0±4,5 12,9±2,1 
diabetes 4,2±1,2 7,8±1,4 6,7±2,5 
14 intact 6,8±2,1 11,9±3,7 13,7±3,2 
diabetes 5,4±1,3 6,9±1,2 8,9±4,2 
28 intact 6,6±4,2 12,8±4,5 14,3±5,2 
diabetes 5,3±1,1 7,9±1,0 11,3±2,1 
Total area of 
β-cells,% 
3 intact 51,3±9,2 64,6±9,1 78,2±6,1 
diabetes 43,4±4,9 52,4±3,4 65,7±3,4 
7 intact 53,8±7,6 63,4±7,0 75,4±7,7 
diabetes 44,6±4,2 53,2±6,1 57,7±3,3* 
14 intact 51,1±7,5 65,2±6,0 77,4±4,4 
diabetes 37,4±5,6 47,6±4,3* 56,2±4,2* 
28 intact 54,3±5,4 66,2±3,6 77,3±4,3 
diabetes 41,2±2,3 50,2±3,1* 67,8±2,6 
Total area of 
β-cell nuclei, 
µm2 
3 intact 24,2±1,2 24,4±1,0 23,9±0,2 
diabetes 26,4±1,1 26,8±1,0 26,5±0,9* 
7 intact 24,3±1,3 23,8±1,2 24,7±1,0 
diabetes 29,8±1,0* 29,6±1,2* 30,1±0,6* 
14 intact 23,9±1,2 24,2±1,2 24,6±1,2 
diabetes 29,1±1,3* 29,6±1,0* 30,0±1,0* 
28 intact 24,4±1,0 24,3±1,2 24,7±2,0 
diabetes 28,7±1,2* 28,7±1,1* 29,7±1,2* 
* - Significant difference compared with the intact control (p <0.05). 
Table 11. Morphometric indicators of pancreatic islets in rats with experimental streptozotocin-
nicotinamide-induced diabetes (M ± m) 
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Day 
experiment 
Intact 
control 
Alloxan-
induced 
diabetes 
Streptozotocin-
induced diabetes 
Immune- 
dependent 
diabetes 
Streptozotocin-
nicotinamide-
induced diabetes 
3 4,1±0,2 10,2±1,2* 3,9±0,1 - 5,1±1,8 
7 3,9±0,1 17,4±0,9* ^ 4,0±1,1 28,6±1,5* 5,4±2,1 
14 4,2±1,0 14,9±1,0* ^ 32,3±4,2* 35,2±2,9*# 4,8±1,9 
28 4,0±1,1 12,5±0,6* # 21,3±2,2* # 30,3±2,7* 5,0±4,1 
* - Significant difference compared with the intact control (p <0.05) ^ - significant difference compared with day 3 of 
experiment (p <0.05); # - significant difference compared with day 7 of experiment (p <0.05). 
Table 12. Apoptotic index of β-cells (%) 
Thus, hyperglycemia as well as reduced plasma C-peptide concentrations are common to 
experimental streptozotocin-nicotinamide-induced diabetes. Along with biochemical 
changes, it displays some characteristic morphological changes, including a statistically 
significant decrease in insular cell area associated with hypertrophy of β-cell nuclei, mosaic 
islet damage resulting in the destruction of endocrine cells as well as sclerotic changes of 
pancreatic islets during long-term observation period. 
 
 
A. Intact control B. Alloxan-induced diabetes 
 
C. Streptozotocin-induced diabetes D. Immune-dependent diabetes 
 
Pancreatic Islet Beta-Cell Apoptosis in Experimental Diabetes Mellitus 
 
241 
E. Streptozotocin-nicotinamide-induced diabetes 
Figure 2. Reduction in the amount of cells under different experimental diabetes conditions, day 14 
(Streptozotocin-induced diabetes, day 7), splenic segment of the pancreas. Primary antibody against 
insulin, DAB staining. Magnification: х400 
 
 
A. Intact control B. Alloxan-induced diabetes 
 
C. Streptozotocin-induced diabetes D. Immune-dependent diabetes 
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E. Streptozotocin-nicotinamide-induced diabetes 
Figure 3. TRAIL expression in pancreatic islet cells under different experimental diabetes conditions, 
day 14 (Streptozotocin-induced diabetes, day 7), splenic segment of the pancreas. TRAIL primary 
antibody, DAB staining. Magnification: х400. 
 
 
A. Intact control B. Alloxan-induced diabetes 
 
C. Streptozotocin-induced diabetes D. Immune-dependent diabetes 
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E. Streptozotocin-nicotinamide-induced diabetes 
Figure 4. Apoptotic cells under different experimental diabetes conditions, day 14 (Streptozotocin-
induced diabetes, day 7), splenic segment of the pancreas. Caspase 3 primary antibody, DAB staining. 
Magnification: х400. 
4. Discussion 
It is known that type I diabetes develops when pancreatic β-cells are damaged due to certain 
inflammatory, autoimmune and other pathological processes. Selective organ-specific tissue 
destruction of the insulin-producing pancreatic β-cells is associated with insulin deficiency 
resulting in impairment of glucose homeostasis. A large body of experimental evidence 
emphasizes the key role of apoptosis in the pathogenesis of diabetes mellitus (Kim B.M. et 
al. 2001; Severgina E.S. 2002; Butler A.E. et al. 2003; Bertalli E. et al. 2005; Rees D.A., et al. 
2005; Srinivasan K., et al. 2007; Islam S., et al. 2009; Pisarev V.B. et al. 2009). Toxic effects of 
certain chemicals (e.g. alloxan, streptozotocin, etc.) used to induce diabetes specifically in 
pancreatic β-cells, manifest themselves by alkylation of DNA and formation of toxic 
compounds, such as superoxide anion, peroxynitrite, and nitric oxide. Damage to DNA and 
intracellular structures causes necrosis and activates apoptosis of pancreatic β-cells (Daisy 
Mythili M., et al. 2004). 
Selective toxicity of streptozotocin can be explained by destruction of antiradical protective 
system and pancreatic β-cell DNA fragmentation. Numerous experiments show that the 
principal cause of streptozotocin-induced β-cell death is alkylation of DNA. Exposure of 
cells to streptozotocin results in the formation of toxic compounds, such as superoxide 
anion, peroxynitrite, and nitric oxide (NO). However, the contribution of NO to the 
cytotoxic activity remains controversial, because low concentrations of NO in the cells 
inhibit the inducible forms of NO-synthase, thus reducing DNA fragmentation (Szkudelski 
T. 2001; Lenzen S. 2008). 
Receptor- or mitochondrial-mediated pathway may trigger programmed pancreatic β-cell 
death (Szkudelski T. 2001). Induction of β-cell apoptosis can occur through a TRAIL-
mediated mechanism. DNA damage can activate p53 gene which regulates the expression of 
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DR5 and/or DR4 death receptors, thus enhancing TRAIL-induced apoptosis (Haupt S., et al. 
2003; Kelley R.F., et al. 2005). Our studies provide evidence for activation of TRAIL-induced 
apoptosis in pancreatic β-cells by administration of streptozotocin on models of 
streptozotocin-induced and immune-dependent diabetes. 
Mitochondrial-mediated apoptotic pathway plays an important role in the development of 
pancreatic islet damage in diabetes mellitus (Sakurai K., et al. 2001). In alloxan-induced 
diabetes intracellular calcium homeostasis is typically impaired. In vitro and in vivo 
experiments have shown that cytoplasmic calcium concentrations increase in the cells of 
pancreatic islets. This effect is due to depolarization of cell and mitochondrial membranes of β-
endocrine cells which is associated with excessive entry of calcium from the extracellular fluid 
and intracellular calcium mobilization (Crow M.T., et al. 2004; Jung J.Y., et al. 2004). Thus, 
considerable gross damage to the intracellular structures by free radicals, oxidation of SH- 
proteins and impairment of intracellular calcium homeostasis typically result in necrosis and 
apoptosis, with necrotic processes being more common in alloxan-induced diabetes. 
Comparison of morphological data and the dynamics of impairment of β-cell functional 
activity in experimental models (alloxan-, streptozotocin-, nicotinamide-streptozotocin-
induced and immune-dependent diabetes) gives insight into the pathogenesis of 
experimental diabetes. A high apoptotic index and the prevalence of destructive processes, 
which enable us to assess not only the extent of pancreatic tissue damage but also to 
evaluate biochemical parameters, such as plasma glucose, insulin, C-peptide, etc., can be 
used as markers of severity of experimental diabetes (Snigur G.L., Smirnov A.V. 2010). 
Thus, apoptosis is a complex, multi-step, poorly regulated process. Any regulatory 
impairment can lead to the development of pathological changes in the endocrine apparatus 
of pancreatic islets including the development of experimental diabetes (Reed J.C., Green 
D.R. 2011). Each level and element of this system is a potential drug target. The significance 
of apoptosis determines the need for the refocusing of biomedical research from theoretical 
biology to clinical medicine. Investigation of apoptotic mechanisms in various pathological 
conditions enable us to make more accurate diagnoses and prognoses as well as to adjust 
therapy. The possibility of deliberate control of apoptotic processes is considered to be the 
basis for developing new medications used to treat many socially important diseases, 
including the development of anti-diabetic drugs. 
Experimental diabetic rats exhibited significant pathohistological changes in the pancreatic 
islets caused by cytotoxine (streptozotocin+CFA) at all levels of tissue structure. The 
development of diabetes mellitus was associated with decreased volume fraction of 
pancreatic islets and β-cells due to inflammation (insulitis) and pronounced destructive 
changes (e.g. necrosis and apoptosis). 
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